title: A phase I dose-ranging study of bendamustine and rituximab in chronic lymphocytic leukemia patients with comorbidities.
authors.affiliation: Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
authors.forename: Alexey V
authors.initials: AV
authors.lastname: Danilov
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Lionel D
authors.initials: LD
authors.lastname: Lewis
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Frederick
authors.initials: F
authors.lastname: Lansigan
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Liya
authors.initials: L
authors.lastname: Roudaia
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Darcie L
authors.initials: DL
authors.lastname: Findley
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Susan Y
authors.initials: SY
authors.lastname: Jones
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Brian
authors.initials: B
authors.lastname: Highhouse
authors.affiliation: Department of Medicine, Geisel School of Medicine and the Norris Cotton Cancer Center at Dartmouth, Lebanon, NH, USA.
authors.forename: Bernard B
authors.initials: BB
authors.lastname: Beaulieu
authors.affiliation: Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
authors.forename: Jennifer R
authors.initials: JR
authors.lastname: Brown
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D000069461:Bendamustine Hydrochloride / Q000008:administration & dosage; D015897:Comorbidity; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D000069283:Rituximab / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000069283:Rituximab; D000069461:Bendamustine Hydrochloride
keywords: bendamustine; chronic lymphocytic leukaemia; comorbidities